Home›Companies›Biotech & Pharma›Helicore Bioventures I

Helicore Bioventures I, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 19, 2024·Suggest an edit

About Helicore Bioventures I

Helicore Bioventures I is a private company based in New York, New York, incorporated in 2023 in Delaware. It has reported $14,999,997 raised in one offering on Form D since January 2024. Its chief executive is Jing Liang.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 10, 2024Jan 19, 2024$14,999,997of $65.0M target8$1.8MEquity, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Helicore Bioventures I's Form D filed Jan 19, 2024.

HJ
Hugh Rienhoff, Jr.
Director and promoter
PC
Patrick Crutcher
Executive officer and promoter
RG
Rishi Gupta
Director
JL
Jing Liang
Chief Executive Officer and director
BL
Brian Liu
Director
CR
Carl Rizzuto
Director

Sources

  1. SECHelicore Bioventures I, Inc. filing history